Abstract: The present invention is directed to substituted five membered heteroaryl benzamide compounds of formula (I) (Formula (I)) which are tropomyosin-related kinase (Trk) family protein kinase inhibitors, and hence are useful in the treatment of pain, inflammation, cancer, restenosis, atherosclerosis, psoriasis, thrombosis, a disease, disorder, injury, or malfunction relating to dysmyelination or demyelination or a disease or disorder associated with abnormal activities of nerve growth factor (NGF) receptor TrkA.

Abstract: An image forming apparatus receives image data by a receiver from an external device and forms an image based on the received image data. The image forming apparatus transmits an address of the receiver to the external device. The image forming apparatus receives image data transmitted with the address by the external device. The communication between the external device and the image forming apparatus is performed wirelessly. The image forming apparatus prints image data in accordance with an accepted printing condition.

Abstract: The present invention relates to chemical compounds of formula (I), with the substituents as described in the specification, useful in the positive modulation of the alpha 7 nicotinic acetylcholine receptor (?7 nAChR). The invention also relates to the use of these compounds in the treatment or prevention of a broad range of diseases in which the positive modulation of ?7 nAChR is advantageous, including neurodegenerative and neuropsychiatric diseases and also neuropathic pain and inflammatory diseases.

Abstract: Disclosed herein are methods of using anti-ILT5 antibodies and ILT5-binding fragments thereof to induce an immunostimulatory effect in a T cell when such a T cell is contacted with an antigen presenting cell (APC) that has been previously contacted with the anti-ILT5 antibody or ILT5-binding fragment. Also disclosed herein are methods of using anti-ILT5 antibodies and ILT5-binding fragments thereof to inhibit a response in a T cell (e.g., a proliferative response) when such a T cell is concomitantly contacted, or has previously been contacted, with an APC, which APC is simultaneously contacted with the anti-ILT5 antibody or ILT5-binding fragment. Also disclosed herein are methods of using anti-ILT5 antibodies and ILT5-binding fragments thereof for the treatment of various diseases and for use as immunostimulatory adjuvants.

Abstract: A power for a physical uplink channel is determined based on whether or not PCMAX that is a maximum transmit power for a terminal device is exceeded, in a case where dual connectivity is not configured for the physical uplink channel, and a power for the physical uplink channel in a first cell group is determined based on whether or not PMCG that is a maximum transmit power for the first cell group is exceeded, a power for the physical uplink channel in a second cell group is determined based on whether or not PSCG that is a maximum transmit power for the second cell group is exceeded, PMCG is calculated by an arithmetic operation that uses at least PCMAX and PSeNB, and PSCG is calculated by an arithmetic operation that uses at least PCMAX and PMeNB, in a case where the dual connectivity is configured for the physical uplink channel.

Abstract: In an LTE-A system, there is a problem that it is difficult to perform stable communication in a case where there is a time when another system occupies an unlicensed band being used. There is provided a base station apparatus that communicates with a terminal device in a second frequency band different from a first frequency band capable of being used as a dedicated frequency band. The base station apparatus includes: a wireless transmission unit that transmits data or control information to the terminal device; and a wireless reception unit that receives data or control information transmitted from the terminal device.

Abstract: A smartphone comprising: a liquid crystal panel having a display surface having a quadrangular display area defined therein; a cover panel; an input unit disposed so as to be located outside the display area such that one side section included in four side sections defining the display area is located between the input unit and the display area, the input unit converting input bone conduction sound transmitted through the cover panel into an input signal; and an output unit disposed so as to be located outside the display area such that the one side section included in the four side sections defining the display area and located between the display area and the input unit is located between the output unit and the display area, the output unit converting an output signal and transmitting the same as output bone conduction sound to the cover panel.

Abstract: A terminal device that communicates with a base station apparatus includes a transmission unit that transmits a channel and/or a signal based on a maximum output power in a first cell group in a certain subframe. In a case where information relating to uplink transmission in the second cell group is recognized, a residual power is allocated based on a priority level of a type of uplink transmission. The residual power is given by subtracting a power that is determined based on uplink transmission in the first cell group and a power that is determined based on the uplink transmission in the second cell group from a sum of maximum output powers of the terminal device. The maximum output power is a sum of the power that is determined based on the uplink transmission in the first cell group and a power that is allocated to the first cell group, of the residual power.

Abstract: When a clock signal pulse number and a compensation-target-line address indicating a compensation-target row match, the following control is carried out with a time point being a starting point of a current measurement period, the time point being one horizontal scanning period after a time point of the match. At a current measurement period starting point and ending point, only the potential of the one of the clock signals applied to a unit circuit corresponding to the compensation-target row is changed. Throughout the current measurement period, the clock operation of the clock signals is stopped. A monitor enable signal, that is applied to a control terminal of an output control transistor for controlling active signal output to a monitor control line, is only set to a high level during the current measurement period.

Abstract: Provided are a communication control method and the like for enabling a terminal device to connect to a core network and move in a communication system in which multiple core networks are overlaid. A base station device receives a tracking area update request, determines a location management device to connect to on the basis of a setting in the base station device, and transmits a tracking area update request. The location management device requests information pertaining to a terminal device to the location management device to which the terminal device was connected prior to moving, and then the location management device to which the terminal device was connected prior to moving or the location management device which received the tracking area update request from the base station device determines whether resetting of the location management device is necessary. Thus, it is possible to control which core network the terminal device connects to.

Abstract: In a water purifier, a flow system includes a first channel in which liquid is filtrated in at least one of a first filter tank and a second filter tank, a second channel in which the liquid is filtrated in the second filter tank and the first filter tank is washed, and a third channel in which the liquid is filtrated in the first filter tank and the second filter tank is washed. A switching lever actuates valve mechanisms to perform switching among the first, second, and third channels such that the channels are selected cyclically in order of the first channel, the second channel, the first channel, the third channel and the first channel. The valve mechanisms work with operation of the switching lever.

Abstract: Provided are an illumination device capable of improving the uniformity in brightness of the illumination light, and a display device using the same. An illumination device is provided with: a plurality of light sources arranged in a row in one direction; and a light guide plate which has, along a side edge face, a light receiving face facing the light source, guides light entering through the light receiving face, and outputs illumination light from a light emitting surface disposed on the front surface; the light guide plate having a plurality of prisms and a plurality of prisms provided in an indented manner on the front or rear surface and arranged in a row along the longitudinal direction of the light receiving face; the prisms being formed spanning between the light receiving face and the opposing face opposite the light receiving face; and the prisms being formed, between adjacent prisms, deeper than the prisms within a predetermined range in the vicinity of the light receiving face.

Abstract: A terminal apparatus, which performs communication with a first base station apparatus and a second base station apparatus which has a smaller maximum transmit power than that of the first base station apparatus, includes a control unit that extracts control information from signals received from the first base station apparatus and the second base station apparatus and sets communication parameters of an uplink data signal, in which a bit number of information which is extracted by the control unit as the control information from the signal from the second base station apparatus is smaller than a bit number of information which is extracted as the control information from the signal from the first base station apparatus.

Abstract: A sheet transporting device in which a curved transport path is provided downstream in a sheet transport direction from a merging section where a plurality of transport paths, which are formed by transport guides for transporting sheets, merge, is provided. The sheet transporting device includes a sheet guide member that extends towards the curved transport path from the merging section, with an extending end portion of the sheet guide member being disposed so as not to contact the transport guides. The sheet guide member reduces jumping up of a trailing end portion of a sheet caused by flexing of the sheet passing through the merging section towards the curved transport path.

Abstract: The invention provides compounds for inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds. The invention also provides methods of treating diseases and disorders related to deficiency or overexpression of O-GlcNAcase, accumulation or deficiency of O-GlcNAc.

Abstract: A mobile station apparatus receives an indication and access restriction information, where the indication indicating whether the cell is a Closed Subscriber Group (CSG) cell, where the CSG cell configured to restrict an access of the mobile station apparatus that are not being registered, and where the access restriction information indicating an access restriction related to an emergency call. The mobile station apparatus also transmits a connection request message for the emergency call based on the access restriction information, where the cell on which the mobile station apparatus camped being the CSG cell and where the mobile station apparatus not registering the cell.

Abstract: The present invention provides a method for manufacturing a liquid crystal display device capable of suppressing display unevenness around a seal in the case of performing PS treatment on a horizontal alignment film formed from a photoactive material. The method for manufacturing a liquid crystal display device of the present invention includes the steps of: forming a horizontal alignment film containing a photoactive material on at least one substrate of a pair of substrates; dropping a liquid crystal composition containing a liquid crystal material and a monomer on one of the pair of substrates, the monomer being contained in an amount of 1.

Abstract: A mobile station apparatus receives information indicating an event and parameters for evaluating a condition of the event using a first cell or a second cell wherein the condition of the event is evaluated for a neighboring cell on associated frequency of the second cell. A base station apparatus configures the first cell and the second cell. The mobile station apparatus also determines whether the neighboring cell is an applicable cell based on one or more cell identifications and evaluates the condition of the event, where the second cell is not an applicable cell when the first cell and the second cell are used for a carrier aggregation.

Abstract: A method of manufacturing a circuit substrate comprising a semiconductor element disposed on a transparent substrate, includes: forming an island-shaped oxide semiconductor layer on the transparent substrate; forming a patterned etch-stop layer made of an insulating material so as to cover at least a center portion of the island-shaped oxide semiconductor layer; depositing a conductive layer over an entire surface of the transparent substrate including a region over the patterned etch-stop layer; forming a patterned resist on the conductive layer; and etching the conductive layer using the patterned resist as a mask to form a patterned conductive layer from the conductive layer, wherein the patterned conductive layer includes a source electrode, a source wiring line, and a drain electrode, and continuing to etch the island-shaped oxide semiconductor thereunder using the patterned conductive layer and the patterned etch-stop layer as a mask to form a cutout in the island-shaped oxide semiconductor layer.

Abstract: The invention provides certain thiazole-substituted aminoheteroaryl compounds of the Formula (I) (I), or pharmaceutically acceptable salts thereof, wherein ring R1, R2, R3, R4, ring A, and the subscripts n1, n2, and r are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk).